Quarterly report pursuant to Section 13 or 15(d)

Schedule of net income per common share (Details)

v3.22.1
Schedule of net income per common share (Details) - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Net loss $ (2,537,514) $ (1,276,138)
Weighted Average Outstanding Shares:    
Outstanding shares 44,667,977 43,960,936
Option shares includable [1] 0 0
 Total 44,667,977 43,960,936
Net loss per share    
Basic $ (0.06) $ (0.03)
Diluted $ (0.06) $ (0.03)
Restricted Stock [Member]    
Net loss per share    
Antidilutive Securities excluded from computation of earnings per share, amount 1,000,000 0
Employee Stock [Member]    
Net loss per share    
Antidilutive Securities excluded from computation of earnings per share, amount 346,020 183,681
Common Stock [Member]    
Net loss
Weighted Average Outstanding Shares:    
Outstanding shares 44,667,977 43,960,936
[1] For the three months ended March 31, 2022 and March 31, 2021, option shares of 346,020 and 183,681 were not included as the impact is anti-dilutive.  For the three months ended March 31, 2022 and March 31, 2021, restricted shares of 1,000,000 and zero respectively, were not included as the impact is anti-dilutive.